4 Clinical evidence in T2DM management A wide range of clinical trials and research have been performed to assess the effectiveness, safety, and tolerability of short-acting against long-acting GLP-1 analogues in the treatment and management of T2DM and obesity
These findings are still emerging, and much of the research to date comes from animal and laboratory studies
Planning this transition with your healthcare team helps you prepare psychologically and identify strategies to maintain health during the off-medication months
Egr-1 plays important roles in regulating cell proliferation and tissue remodeling
Cheng Z, Cheng Y, Chen Q, Li M, Wang J, Liu H, Li M, Ning Y, Yu Z, Wang Y, et al
Regain is the expected physiological response when GLP-1 medications stop because appetite-suppression signals end